CP
CASI Pharmaceuticals Inc
🇺🇸XNAS.CASIUnited StatesHealthcare
$0.14USDdown -0.02 (-12.5%)ClosedEnd of day9:09 AM
Price$0.14-0.02 (-12.5%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US14757U1097
- CUSIP
- 29382F103
Company
- Employees
- 233
- Headquarters
- Beijing, United States
- CEO
- Mr. David A. Cory M.B.A., R.Ph.
Market
- Shares outstanding
- 20.5M
- Market cap
- $2.17M
Highlights
- Market cap
- $2.17M
- EPS LTM
- -$2.40calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -0.06calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $26.85M+21.72%up year on year
- Net income
- -$49.38M-59.58%down year on year
- Gross margin
- 35.8%-34.08%down year on year
- Free cash flow
- Not reported
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.